13G Filing: Sabby Capital and Arca Biopharma Inc. (ABIO)
Sabby Healthcare Master Fund, Ltd | 0 | 446,052 | 0 | 446,052 | 446,052 | 3.80 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 00211Y407 1.
Arca Biopharma Inc. (ABIO)
Market is closed
News
- Displaying 3
Venrock's Latest Pick Shows There Are More Biotech Opportunities to Explore
Biotech is a hot segment right now and even though it has many opportunities, it is also associated with a lot of risks.
RA Capital Is Expecting A Breakthrough Cardiovascular Drug From This Biotech
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Billionaire Hedge Funds
